Zobrazeno 1 - 8
of 8
pro vyhledávání: '"William Donnellan"'
Autor:
Pankit Vachhani, Esprit Ma, Tao Xu, Melissa Montez, Sarah Worth, Archibong Yellow‐Duke, Wei‐Han Cheng, Michael E. Werner, Jonathan Abbas, William Donnellan
Publikováno v:
Cancer Medicine, Vol 12, Iss 17, Pp 17914-17923 (2023)
Abstract Background This retrospective cohort study used an electronic health record‐derived, de‐identified, US patient‐level database to better understand the real‐world treatment experience, in a predominantly community setting (80.3% of pa
Externí odkaz:
https://doaj.org/article/3fb93e699c154e0782e4f2e27479dc7b
Autor:
Michael Boyiadzis, Pinkal Desai, Nikki Daskalakis, William Donnellan, Lucille Ferrante, Jenna D. Goldberg, Michael R. Grunwald, Christina Guttke, Xiang Li, Jose Antonio Perez‐Simon, Olga Salamero, Trevor Tucker, Xiaoying Xu, Jay Yang, Naveen Pemmaraju, Juan Manuel Alonso‐Dominguez
Publikováno v:
Clinical and Translational Science, Vol 16, Iss 3, Pp 429-435 (2023)
Abstract This study aimed to identify a recommended phase II dose and evaluate the safety, tolerability, pharmacokinetics/pharmacodynamics, and preliminary clinical activity of JNJ‐63709178, a CD123/CD3 dual‐targeting antibody, in patients with r
Externí odkaz:
https://doaj.org/article/2ed30f1b9d9b4b9aad49fe1caf9fdf6d
Autor:
Stephen Couban, Giulia Benevolo, William Donnellan, Jennifer Cultrera, Steffen Koschmieder, Srdan Verstovsek, Gregory Hooper, Christian Hertig, Maneesh Tandon, Natalie Dimier, Vikram Malhi, Francesco Passamonti
Publikováno v:
Journal of Hematology & Oncology, Vol 11, Iss 1, Pp 1-4 (2018)
Abstract Background The JAK inhibitor (JAKi) ruxolitinib is standard treatment for myelofibrosis (MF), but some patients are unresponsive. Pre-clinical and clinical data suggest that addition of a Hedgehog pathway inhibitor (HPI) to ruxolitinib might
Externí odkaz:
https://doaj.org/article/f3b5023c148b4fdd86ea6f5993a73a76
Autor:
Manish R. Patel, William Donnellan, Michael Byrne, Adam S. Asch, Amer M. Zeidan, Maria R. Baer, Amir T. Fathi, Andrew T. Kuykendall, Fred Zheng, Chris Walker, Lulu Cheng, Cindy Marando, Michael R. Savona
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a7fcc232d5a395aa6a48ca719ecfdc3
https://doi.org/10.1016/j.clml.2023.05.002
https://doi.org/10.1016/j.clml.2023.05.002
Autor:
Pankit Vachhani, Esprit Ma, Tao Xu, Melissa Montez, Sarah Worth, Wei-Han Cheng, Michael Werner, Jonathan Abbas, William Donnellan
Publikováno v:
Blood. 140:683-684
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f39ad4bdb43451cc0676c3795f346a20
https://doi.org/10.1182/blood-2022-157509
https://doi.org/10.1182/blood-2022-157509
Autor:
Pankit Vachhani, Evelyn M Flahavan, Tao Xu, Esprit Ma, Melissa Montez, Anda Gershon, Maika Onishi, Huan Jin, Grace Ku, Brannon Flores, Cat N Bui, Jonathan A Abbas, William Donnellan
Publikováno v:
The oncologist. 27(11)
Background Treatment with venetoclax + hypomethylating agents (HMAs) is standard-of-care for newly diagnosed (ND) patients with acute myeloid leukemia (AML) aged ≥75 years, or with comorbidities precluding intensive chemotherapy. We describe real-w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a99f75535fd5f0b44ab8106a72d3f2af
https://pubmed.ncbi.nlm.nih.gov/35925602
https://pubmed.ncbi.nlm.nih.gov/35925602
Autor:
Aaron T. Gerds, Bart L. Scott, Peter Greenberg, Tara L. Lin, Daniel A. Pollyea, Amit Verma, Monique Dail, Yuning Feng, Cherie Green, Connie Ma, Bruno C. Medeiros, Mark Yan, Kasra Yousefi, William Donnellan
Publikováno v:
Blood advances. 6(4)
We present primary results from the phase 1b GO29754 study evaluating the safety and tolerability of atezolizumab, a programmed death-ligand 1 inhibitor, alone and in combination with azacitidine, a hypomethylating agent (HMA), in patients with relap
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d626d1831e71612af1745fc8bd39a0ee
https://pubmed.ncbi.nlm.nih.gov/34932793
https://pubmed.ncbi.nlm.nih.gov/34932793
Publikováno v:
Biology of Blood and Marrow Transplantation. 20(2):S162-S163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b7c98e55a8dee7d40882071716a81fe4